| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |